| P50 | author | Steven W. Levison | Q46521372 |
| P2093 | author name string | Mariano Guardia Clausi | |
| P2860 | cites work | Regulation of endothelial cell plasticity by TGF-β | Q26862059 |
| | Induction of transforming growth factor beta receptors following focal ischemia in the rat brain | Q27312629 |
| | TGFbeta1 stimulates the over-production of white matter astrocytes from precursors of the "brain marrow" in a rodent model of neonatal encephalopathy | Q27333559 |
| | The yin and yang of microglia | Q27693871 |
| | Role of transforming growth factor beta in human disease | Q28143408 |
| | Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat | Q28189196 |
| | TGF-{beta}1 activates two distinct type I receptors in neurons: implications for neuronal NF-{kappa}B signaling | Q28569079 |
| | Serum cytokines in a clinical trial of hypothermia for neonatal hypoxic-ischemic encephalopathy. | Q30424622 |
| | TGFβ signaling in the brain increases with aging and signals to astrocytes and innate immune cells in the weeks after stroke. | Q30479052 |
| | Tests to assess motor phenotype in mice: a user's guide | Q33464903 |
| | Astrocytic transforming growth factor-beta signaling reduces subacute neuroinflammation after stroke in mice | Q33769818 |
| | Astrocytic TGF-β signaling limits inflammation and reduces neuronal damage during central nervous system Toxoplasma infection | Q33822879 |
| | Intraventricular haemorrhage and posthaemorrhagic hydrocephalus: pathogenesis, prevention and future interventions | Q34324897 |
| | Reactive astrocytes in neural repair and protection | Q34449475 |
| | Transforming growth factor-beta and ischemic brain injury | Q35545534 |
| | Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals | Q35820693 |
| | The pathogenesis of neonatal post-hemorrhagic hydrocephalus | Q35901290 |
| | Glia-dependent TGF-beta signaling, acting independently of the TH17 pathway, is critical for initiation of murine autoimmune encephalomyelitis. | Q36088936 |
| | Central nervous system injury-induced immune deficiency syndrome | Q36257627 |
| | The role of inflammation in perinatal brain injury | Q36331560 |
| | Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta | Q36350227 |
| | Opposite effect of inflammation on subventricular zone versus hippocampal precursors in brain injury | Q36467173 |
| | Effects of combination therapy using hypothermia and erythropoietin in a rat model of neonatal hypoxia-ischemia | Q36518208 |
| | Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6 | Q36631212 |
| | Digestion products of the PH20 hyaluronidase inhibit remyelination | Q36718003 |
| | Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. | Q36719103 |
| | Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice | Q37468752 |
| | Glial scar formation occurs in the human brain after ischemic stroke. | Q37605393 |
| | Inhibition of transforming growth factor-β attenuates brain injury and neurological deficits in a rat model of germinal matrix hemorrhage | Q37664339 |
| | Neuronal TGF-beta1 mediates IL-9/mast cell interaction and exacerbates excitotoxicity in newborn mice. | Q40471604 |
| | Inhibitors of myelination: ECM changes, CSPGs and PTPs. | Q40804371 |
| | Increased p38 mitogen-activated protein kinase signaling is involved in the oxidative stress associated with oxygen and glucose deprivation in neonatal hippocampal slice cultures | Q41990876 |
| | Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats | Q42170483 |
| | A cellular stress model for the sequestration of redox-active glial iron in the aging and degenerating nervous system | Q42490290 |
| | Suppression of fibrotic scar formation promotes axonal regeneration without disturbing blood-brain barrier repair and withdrawal of leukocytes after traumatic brain injury | Q42961203 |
| | Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats | Q43727683 |
| | Cerebral and hepatic inflammatory response after neonatal hypoxia-ischemia in newborn rats | Q43943626 |
| | Soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro differentiation of purified rat oligodendroglial lineage cells. | Q44264171 |
| | SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7. | Q44772939 |
| | Astroglial overproduction of TGF-beta 1 enhances inflammatory central nervous system disease in transgenic mice . | Q46004205 |
| | Temporal expression of cytokines and signal transducer and activator of transcription factor 3 activation after neonatal hypoxia/ischemia in mice | Q48089794 |
| | A novel preclinical rodent model of collagenase-induced germinal matrix/intraventricular hemorrhage. | Q48097025 |
| | Induction of communicating hydrocephalus in mice by intrathecal injection of human recombinant transforming growth factor-beta 1. | Q48164036 |
| | Relation between TGF-beta 1 levels in cerebrospinal fluid and ETV outcome in premature newborns with posthemorrhagic hydrocephalus | Q48435614 |
| | Hemispheric brain injury and behavioral deficits induced by severe neonatal hypoxia-ischemia in rats are not attenuated by intravenous administration of human umbilical cord blood cells | Q48621483 |
| | Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1 | Q48655440 |
| | Delayed cerebral atrophy following moderate hypoxia-ischemia in the immature rat. | Q48747298 |
| | Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats | Q48907105 |
| | Tactile extinction: distinguishing between sensorimotor and motor asymmetries in rats with unilateral nigrostriatal damage | Q48971743 |
| | Very delayed infarction after mild focal cerebral ischemia: a role for apoptosis? | Q49108868 |
| | Systemic inflammation disrupts the developmental program of white matter. | Q50998316 |
| | Overexpression of TGF-beta 1 in the central nervous system of transgenic mice results in hydrocephalus. | Q52208539 |
| | A Transforming Growth Factor-β Antagonist Unmasks the Neuroprotective Role of This Endogenous Cytokine in Excitotoxic and Ischemic Brain Injury | Q60597724 |
| | Posture-independent sensorimotor analysis of inter-hemispheric receptor asymmetries in neostriatum | Q70435544 |
| | Transforming growth factor-beta1: a possible signal molecule for posthemorrhagic hydrocephalus? | Q73131936 |
| | Neurologic examination of preterm infants at term age: comparison with term infants | Q73600790 |
| | Expression of IL-6 in the ischemic penumbra | Q73735710 |
| | Can lateralizing sensorimotor deficits be identified after neonatal cerebral hypoxia-ischemia in rats? | Q76333945 |
| P433 | issue | 3 | |
| P921 | main subject | TGF-beta RI inhibitor III | Q27088976 |
| P304 | page(s) | 787-800 | |
| P577 | publication date | 2016-07-20 | |
| P1433 | published in | Journal of Cerebral Blood Flow & Metabolism | Q14663525 |
| P1476 | title | Delayed ALK5 inhibition improves functional recovery in neonatal brain injury | |
| P478 | volume | 37 | |